Statistics
Publications
15
Citations
8.8K
H-Index
15
Active since
2003
Stephen D. Rubin is an author at GlaxoSmithKline (United States) specializing in medicine, oncology, and pharmacology.
Publications per year
2003–2018
15
15
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
Charles E. Geyer, John Forster, Deborah Lindquist et al. · New England Journal of Medicine · 2006 · 3.5K citations · Full text
Medicine, Oncology, Pharmacology +17
Cora N. Sternberg, Robert E. Hawkins, John Wagstaff et al. · European Journal of Cancer · 2013 · 446 citations
Medicine, Oncology, Pharmacology +11
1–5 of 15